Boston Scientific Corporation ( NYSE: BSX) Bank of America’s 2025 Health Care Conference May 13, 2025 11:00 AM ET Daniel Brennan - EVP & CFO Joe Fitzgerald - EVP & Group President, Cardiology ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE ... the highest number of hedge fund holders as of Q4 2024. We sourced the hedge fund sentiment data ...

Explore Terumo's steady growth, strong market leadership, and disciplined expansion. A reliable med-tech investment with long ...

Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

Boston Scientific said on Wednesday it will stop pursuing U.S. approval for its experimental heart device due to increased clinical and regulatory requirements.